It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1980.
1980 | Mumbai, Maharashtra, India | ActivePearim Pharmaceuticals Private Limited, a active private limited company, was established on 25 September 1980 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the financial and insurance service sector, it holds CIN: U24200MH1980PTC023204. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.75 M.
It upholds a compliant status. Its leadership includes Meena Balvant Desai (Director), Vidyut Dilip Shah (Director), Radhika Vidyut Shah (Director). Past directors included Tarulata Jayvantrai Desai, Chandulal Pitambardas Shah, Saurabhkumar Jayavantrai Desai. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 30 Sheila Apartment2 Bhulabhai Desai Rd, Mumbai, Maharashtra, 400026.
U24200MH1980PTC023204
023204
25 September 1980
₹2.00 M
₹0.75 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Pearim Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meena Balvant Desai | Director | 01 Aug 2018 | Current |
| Vidyut Dilip Shah | Director | 12 Jun 2014 | Current |
| Radhika Vidyut Shah | Director | 25 Apr 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Nov 2007 | Past |
| Pramod Abcsdd | Director | 26 Jul 2018 | Past |
| Pramod Abcsdd | Director | 28 May 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pearim Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.68% increase. The company also saw a substantial improvement in profitability, with a 45.91% increase in profit. The company's net worth observed a substantial decline by a decrease of 187.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Pearim Pharmaceuticals had a promoter holding of 86.67% and a public holding of 13.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Pearim Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Pearim Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pearim Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Pearim Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Pearim Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Meena Balvant Desai was appointed as a Director was appointed as a Director on 01 Aug 2018 & has been associated with this company since 7 years 4 months . was recorded as a recent event.
Radhika Vidyut Shah was appointed as a Director was appointed as a Director on 25 Apr 2018 & has been associated with this company since 7 years 7 months . was recorded as a recent event.
Progress on Vidyut Dilip Shah was appointed as a Director was appointed as a Director on 12 Jun 2014 & has been associated with this company since 11 years 5 months . was documented.
Pearim Pharmaceuticals Private Limited was registered on 25 Sep 1980 with Roc Mumbai & aged 45 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Pearim Pharmaceuticals Private Limited is U24200MH1980PTC023204.
Pearim Pharmaceuticals Private Limited is headquartered at 30 Sheila Apartment2 Bhulabhai Desai Rd, Mumbai, Maharashtra, 400026.
Pearim Pharmaceuticals Private Limited was incorporated on 25 September 1980.
The current directors of Pearim Pharmaceuticals Private Limited are
The primary industry of Pearim Pharmaceuticals Private Limited is Financial And Insurance Service.
Pearim Pharmaceuticals Private Limited is unlisted.
The authorized capital of Pearim Pharmaceuticals Private Limited is ₹2.00 M, and the paid-up capital is ₹0.75 M.
The compliance status of Pearim Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX